Cargando…
Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure
Autores principales: | Cochino, Alexis Virgil, Farkas, Oana Maria, Ioan, Andreea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212399/ https://www.ncbi.nlm.nih.gov/pubmed/35724754 http://dx.doi.org/10.1016/j.jinf.2022.06.012 |
Ejemplares similares
-
Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent
por: Cinteza, Eliza, et al.
Publicado: (2023) -
Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement
por: García-Maturano, Juan Salvador, et al.
Publicado: (2021) -
IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Ali, Elrazi, et al.
Publicado: (2021) -
The Flare Up of Catastrophic Antiphospholipid Syndrome: a Report of an Immunosuppressive Withdrawal-Induced Case
por: Mortazavimoghaddam, Sayyed Gholamreza
Publicado: (2011) -
Reduced Rate of Disease Flares in Japanese Patients with Systemic Lupus Erythematosus: An Altered Balance between the Use of Glucocorticoids and Immunosuppressants in Recent Decades
por: Imaizumi, Chihiro, et al.
Publicado: (2022)